Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein-Reference-Cited by-同舟云学术

Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein

Published:2018-02 Issue: Volume:150 Page:130-136
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Mercorelli Beatrice,Luganini Anna,Celegato Marta,Palù Giorgio,Gribaudo Giorgio,Loregian Arianna

Funder

Associazione Italiana per la Ricerca sul Cancro (AIRC

University of Padua

University of Torino

Fondazione Umberto Veronesi

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference39 articles.

1. Kinome profiling identifies druggable targets for novel human cytomegalovirus (HCMV) antivirals;Arend;Mol. Cell. Proteom.,2017

2. The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early protein IE2/IEP86 affects temporal viral gene expression;Barrasa;J. Virol.,2005

3. Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins;Beelontally;Antivir. Res.,2017

4. Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection;Berndt;J. Virol.,2009

5. Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies;Boeckh;Biol. Blood Marrow Transplant.,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors;Antiviral Research;2024-03

2. Computational approaches for modeling and structural design of biological systems: A comprehensive review;Progress in Biophysics and Molecular Biology;2023-12

3. HCMV-IE2 promotes atherosclerosis by inhibiting vascular smooth muscle cells’ pyroptosis;Frontiers in Microbiology;2023-05-10

4. Toward inhibition of human cytomegalovirus replication with compounds targeting cellular proteins;Journal of General Virology;2022-10-10

5. Repurposing drugs targeting epidemic viruses;Drug Discovery Today;2022-07